123 related articles for article (PubMed ID: 30526836)
21. [Novel ETO2-GLIS2 fusion and therapeutic strategy in acute megakaryoblastic leukemia].
Thiollier C; Pflumio F; Ballerini P; Crispino JD; Bernard O; Mercher T
Med Sci (Paris); 2012 Nov; 28(11):1013-6. PubMed ID: 23171910
[No Abstract] [Full Text] [Related]
22. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
[TBL] [Abstract][Full Text] [Related]
23. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
[TBL] [Abstract][Full Text] [Related]
24. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
[TBL] [Abstract][Full Text] [Related]
25. Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.
Lopez CK; Noguera E; Stavropoulou V; Robert E; Aid Z; Ballerini P; Bilhou-Nabera C; Lapillonne H; Boudia F; Thirant C; Fagnan A; Arcangeli ML; Kinston SJ; Diop M; Job B; Lecluse Y; Brunet E; Babin L; Villeval JL; Delabesse E; Peters AHFM; Vainchenker W; Gaudry M; Masetti R; Locatelli F; Malinge S; Nerlov C; Droin N; Lobry C; Godin I; Bernard OA; Göttgens B; Petit A; Pflumio F; Schwaller J; Mercher T
Cancer Discov; 2019 Dec; 9(12):1736-1753. PubMed ID: 31662298
[TBL] [Abstract][Full Text] [Related]
26. ERG is a megakaryocytic oncogene.
Salek-Ardakani S; Smooha G; de Boer J; Sebire NJ; Morrow M; Rainis L; Lee S; Williams O; Izraeli S; Brady HJ
Cancer Res; 2009 Jun; 69(11):4665-73. PubMed ID: 19487285
[TBL] [Abstract][Full Text] [Related]
27. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
Crispino JD
Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
[TBL] [Abstract][Full Text] [Related]
28. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
[TBL] [Abstract][Full Text] [Related]
29. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.
Taketani T; Taki T; Sako M; Ishii T; Yamaguchi S; Hayashi Y
Cancer Genet Cytogenet; 2008 Oct; 186(2):115-9. PubMed ID: 18940475
[TBL] [Abstract][Full Text] [Related]
30. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL.
Haemmerling S; Behnisch W; Doerks T; Korbel JO; Bork P; Moog U; Hentze S; Grasshoff U; Bonin M; Rieß O; Janssen JW; Jauch A; Bartram CR; Reinhardt D; Koch KA; Bandapalli OR; Kulozik AE
Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450
[TBL] [Abstract][Full Text] [Related]
31. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
32. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
[TBL] [Abstract][Full Text] [Related]
33. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
[TBL] [Abstract][Full Text] [Related]
34. Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia.
Benbarche S; Lopez CK; Salataj E; Aid Z; Thirant C; Laiguillon MC; Lecourt S; Belloucif Y; Vaganay C; Antonini M; Hu J; da Silva Babinet A; Ndiaye-Lobry D; Pardieu B; Petit A; Puissant A; Chaumeil J; Mercher T; Lobry C
Sci Adv; 2022 Feb; 8(6):eabg9455. PubMed ID: 35138899
[TBL] [Abstract][Full Text] [Related]
35. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
[TBL] [Abstract][Full Text] [Related]
36. Expression of MDR-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells.
Ota S; Sato T; Kakuda H; Hirano K; Okimoto Y; Mori T; Nakazawa S; Kojima S; Matsuyama T; Tsuruo T
Leuk Lymphoma; 1995 Nov; 19(5-6):431-6. PubMed ID: 8590843
[TBL] [Abstract][Full Text] [Related]
37. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
[TBL] [Abstract][Full Text] [Related]
38. High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
Aid Z; Robert E; Lopez CK; Bourgoin M; Boudia F; Le Mene M; Riviere J; Baille M; Benbarche S; Renou L; Fagnan A; Thirant C; Federici L; Touchard L; Lecluse Y; Jetten A; Geoerger B; Lapillonne H; Solary E; Gaudry M; Meshinchi S; Pflumio F; Auberger P; Lobry C; Petit A; Jacquel A; Mercher T
Leukemia; 2023 Mar; 37(3):571-579. PubMed ID: 36585521
[TBL] [Abstract][Full Text] [Related]
39. Frequent detection of
Chen Wongworawat Y; Eskandari G; Gaikwad A; Marcogliese AN; Ferguson LS; Brackett J; Punia JN; Elghetany MT; Kulkarni R; Rao PH; Ringrose J; Lopez-Terrada DH; Roy A; Curry CV; Fisher KE
Leuk Lymphoma; 2023 Feb; 64(2):462-467. PubMed ID: 36346368
[No Abstract] [Full Text] [Related]
40. Detection of RBM15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia.
Takeda A; Shimada A; Hamamoto K; Yoshino S; Nagai T; Fujii Y; Yamada M; Nakamura Y; Watanabe T; Watanabe Y; Yamamoto Y; Sakakibara K; Oda M; Morishima T
Acta Med Okayama; 2014; 68(2):119-23. PubMed ID: 24743787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]